Sy JP - Search Results

1

Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.

Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA, Dreyer RF, Gentile RC, Sy JP, Hantsbarger G, Shams N. Heier JS, et al. Among authors: sy jp. Ophthalmology. 2006 Apr;113(4):633.e1-4. doi: 10.1016/j.ophtha.2005.10.052. Epub 2006 Feb 14. Ophthalmology. 2006. PMID: 16483659 Clinical Trial.

2

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group. Brown DM, et al. Among authors: sy jp. N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655. N Engl J Med. 2006. PMID: 17021319 Free article. Clinical Trial.

3

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group. Brown DM, et al. Among authors: sy jp. Ophthalmology. 2009 Jan;116(1):57-65.e5. doi: 10.1016/j.ophtha.2008.10.018. Ophthalmology. 2009. PMID: 19118696 Clinical Trial.

4

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS; RISE and RIDE Research Group. Nguyen QD, et al. Ophthalmology. 2012 Apr;119(4):789-801. doi: 10.1016/j.ophtha.2011.12.039. Epub 2012 Feb 11. Ophthalmology. 2012. PMID: 22330964 Clinical Trial.

5

Effects of growth hormone treatment in children with cystic fibrosis: the National Cooperative Growth Study experience.

Hardin DS, Sy JP. Hardin DS, et al. Among authors: sy jp. J Pediatr. 1997 Jul;131(1 Pt 2):S65-9. doi: 10.1016/s0022-3476(97)70015-5. J Pediatr. 1997. PMID: 9255232

6

Analysis of bone age data from national cooperative growth study substudy VII.

Kemp SF, Sy JP. Kemp SF, et al. Among authors: sy jp. Pediatrics. 1999 Oct;104(4 Pt 2):1031-6. Pediatrics. 1999. PMID: 10506259

7

The role of serial sampling in the diagnosis of growth hormone deficiency.

Diamond FB, Jorgensen EV, Root AW, Shulman DI, Sy JP, Blethen SL, Bercu BB. Diamond FB, et al. Among authors: sy jp. Pediatrics. 1998 Aug;102(2 Pt 3):521-4. Pediatrics. 1998. PMID: 9685457

8

Optimizing estrogen replacement treatment in Turner syndrome.

Rosenfield RL, Perovic N, Devine N, Mauras N, Moshang T, Root AW, Sy JP. Rosenfield RL, et al. Among authors: sy jp. Pediatrics. 1998 Aug;102(2 Pt 3):486-8. Pediatrics. 1998. PMID: 9685449

9

The effect of growth hormone treatment on stature in Aarskog syndrome.

Petryk A, Richton S, Sy JP, Blethen SL. Petryk A, et al. Among authors: sy jp. J Pediatr Endocrinol Metab. 1999 Mar-Apr;12(2):161-5. doi: 10.1515/jpem.1999.12.2.161. J Pediatr Endocrinol Metab. 1999. PMID: 10392362

10

Effects of recombinant human growth hormone on height and skeletal maturation in growth hormone-deficient children with and without severe pretreatment bone age delay.

Frindik JP, Kemp SF, Sy JP. Frindik JP, et al. Among authors: sy jp. Horm Res. 1999;51(1):15-9. doi: 10.1159/000023307. Horm Res. 1999. PMID: 10095164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters